Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]
Eur Urol Focus
.
2024 Jan;10(1):211.
doi: 10.1016/j.euf.2023.08.006.
Epub 2023 Aug 26.
Authors
Jennifer Linehan
1
,
Josh Gottlieb
2
,
Solomon L Woldu
3
,
Craig Labbate
4
,
Kyle Rose
5
,
Wade Sexton
5
,
Hristos Kaimakliotis
6
,
Joseph Jacob
7
,
Rian Dickstein
8
,
Alan Nieder
9
,
Marc Bjurlin
10
,
Mitchell Humphreys
11
,
Saum Ghodoussipour
12
,
Marcus Quek
13
,
Michael O'Donnell
14
,
Brian H Eisner
15
,
Adam S Feldman
15
,
Surena F Matin
4
,
Yair Lotan
3
,
Katie S Murray
16
Affiliations
1
Providence Specialty Medical Group, Santa Monica, CA, USA.
2
Providence Specialty Medical Group, Santa Monica, CA, USA. Electronic address: jgottlie55@gmail.com.
3
University of Texas Southwestern Medical Center, Dallas, TX, USA.
4
University of Texas MD Anderson Cancer Center, Houston, TX, USA.
5
Moffitt Cancer Center, Tampa, FL, USA.
6
Indiana University Medical Center, Indianapolis, IN, USA.
7
State University of New York Upstate Medical Center, Syracuse, NY, USA.
8
University of Maryland Medical Center, Baltimore Washington Medical Center, Glen Burnie, MD, USA; Chesapeake Urology, Baltimore, MD, USA.
9
Mount Sinai Medical Center, Miami Beach, FL, USA.
10
University of North Carolina Medical Center, Chapel Hill, NC, USA.
11
Mayo Clinic Cancer Center, Phoenix, AZ, USA.
12
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
13
Loyola University Medical Center, Maywood, IL, USA.
14
University of Iowa Health Care, Iowa City, IA, USA.
15
Massachusetts General Hospital, Boston, MA, USA.
16
NYU Langone Health, New York, NY, USA.
PMID:
37640582
DOI:
10.1016/j.euf.2023.08.006
No abstract available
Publication types
Published Erratum